EP Patent

EP3378469A1 — Pharmaceutical composition of simvastatin or salt thereof

Assigned to Wockhardt UK Ltd · Expires 2018-09-26 · 8y expired

What this patent protects

A pharmaceutical composition for oral administration in the form of an aqueous suspension comprising simvastatin or salt thereof, a low hygroscopic excipient; and a buffer, wherein the composition has a pH in the range of about 3.5 to about 4.0. The composition of the present inv…

USPTO Abstract

A pharmaceutical composition for oral administration in the form of an aqueous suspension comprising simvastatin or salt thereof, a low hygroscopic excipient; and a buffer, wherein the composition has a pH in the range of about 3.5 to about 4.0. The composition of the present invention contains less than about 1% of Impurity A when stored at about 25°C and about 60% RH for a period of at least 3 months.

Drugs covered by this patent

Patent Metadata

Patent number
EP3378469A1
Jurisdiction
EP
Classification
—
Expires
2018-09-26
Drug substance claim
No
Drug product claim
No
Assignee
Wockhardt UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.